APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
17 hedge funds and large institutions have $3.23M invested in Aptose Biosciences, Inc. in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
17
Holding in Top 10
–
Calls
$69K
Puts
–
Top Buyers
| 1 | +$438K | |
| 2 | +$251K | |
| 3 | +$236K | |
| 4 |
Morgan Stanley
New York
|
+$171K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$125K |
Top Sellers
| 1 | -$148K | |
| 2 | -$45K | |
| 3 | -$45K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$35.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$13K |